MedTech Business - January 3, 2017
First delivery of Nevisense View for SciBase
SciBase’s new instrument Nevisense View which combines patented impedance measurement (EIS) for early detection of malignant melanoma with visual information from digital dermoscopy, has left SciBase for delivery to Belgium. The new instrument Nevisense View integrates images from digital dermoscopy with Nevisense’s EIS-technology. The result is that all information from a skin examination is gathered […]
Clinical Trials Medtech - June 3, 2014
SciBase presents results from melanoma study
Swedish SciBase AB has announced the British Journal of Dermatology publication of a multi-centre international study for its point-of-care device Nevisense. According to SciBase the study shows that Nevisense provides an accurate and important new tool for the detection of malignant melanoma. Nevisense is a non-visual melanoma detection system, using Electrical Impedance Spectroscopy (EIS) to objectively analyze lesions with […]
